Personalized Medicine in HER2-positive breast cancer

被引：0
|
作者：
Tsurutani, Junji [1 ]
机构：
[1] Kindai Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw459
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISY-8-4
引用
收藏
页数：1
相关论文
共 50 条
  • [41] HER2-positive male breast cancer: an update
    Ottini, Laura
    Capalbo, Carlo
    Rizzolo, Piera
    Silvestri, Valentina
    Bronte, Giuseppe
    Rizzo, Sergio
    Russo, Antonio
    [J]. BREAST CANCER-TARGETS AND THERAPY, 2010, 2 : 45 - 58
  • [42] Preoperative treatment of HER2-positive breast cancer
    Wysocki, Piotr J.
    Krzakowski, Maciej
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (02): : 69 - 74
  • [43] Trastuzumab (herceptin) and HER2-positive breast cancer
    Murray, S
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (01) : 36 - 37
  • [44] Cardiotoxicity in HER2-positive breast cancer patients
    Diana Gonciar
    Lucian Mocan
    Alexandru Zlibut
    Teodora Mocan
    Lucia Agoston-Coldea
    [J]. Heart Failure Reviews, 2021, 26 : 919 - 935
  • [45] Neratinib in HER2-Positive Breast Cancer Patients
    Paranjpe, Rutugandha
    Basatneh, Dima
    Tao, Gabriel
    De Angelis, Carmine
    Noormohammed, Sobia
    Ekinci, Ekim
    Abughosh, Susan
    Ghose, Romi
    Trivedi, Meghana V.
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (06) : 612 - 620
  • [46] HER2-Positive Breast Cancer: Beyond Trastuzumab
    Murphy, Conleth G.
    Fornier, Monica
    [J]. ONCOLOGY-NEW YORK, 2010, 24 (05): : 410 - 415
  • [47] Updates in HER2-Positive Metastatic Breast Cancer
    Gadi, V. K.
    Iyengar, Neil
    Isaacs, Claudine
    Kaklamani, Virginia
    [J]. ONCOLOGY-NEW YORK, 2021, 35 (09): : 588 - 591
  • [48] Frontiers in HER2-positive breast cancer in 2020
    Peddi, Parvin F.
    Slamon, Dennis J.
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (01) : 48 - 52
  • [49] Current challenges in HER2-positive breast cancer
    Puglisi, Fabio
    Fontanella, Caterina
    Amoroso, Vito
    Bianchi, Giulia Valeria
    Bisagni, Giancarlo
    Falci, Cristina
    Fontana, Andrea
    Generali, Daniele
    Gianni, Lorenzo
    Grassadonia, Antonio
    Moscetti, Luca
    Portarena, Ilaria
    Rossi, Emanuela
    Marchetti, Paolo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 211 - 221
  • [50] What is a HER2-positive in breast cancer in 2018?
    Schnitt, S.
    [J]. CANCER RESEARCH, 2019, 79 (04)
12345